GlobalSpace Technologies Inaugurates PATGPT AI Platform for Pharma Sector; Stock Surge

Mumbai, September 25, 2025: Shares of GlobalSpace Technologies Ltd (BSE: 540654) jumped 4.79 percent to ₹16.41 during Thursday’s trade following the company’s global launch of PATGPT, an original pharma-specific Large Language Model (LLM), to transform digital operations in the pharma sector.

Headquartered in Navi Mumbai, GlobalSpace Technologies Ltd is a publicly listed digital solutions firm with a strong focus on healthcare and pharmaceuticals. The company offers SaaS-based platforms and AI technologies that help pharmaceutical companies digitalise sales force operations, promote compliance, and enable improved engagement with healthcare professionals. PATGPT enables the company to enter the fast-growing field of AI applications in healthcare and life sciences.

Stock Performance

As of 12:43 pm IST, the stock was trading ₹0.75 higher at ₹16.41, compared with the previous close of ₹15.66. The counter recorded an intraday high of ₹17.22, the day’s upper price band, while the session low was ₹15.70. Trading activity was notable, with a turnover of ₹15.71 lakh across 0.93 lakh shares. The stock currently has a market capitalization of ₹58.22 crore, a price-to-earnings (P/E) ratio of 62.74, and an earnings per share (EPS) of ₹0.27 on a trailing twelve-month basis. Over the past twelve months, the stock has traded between a low of ₹14.32 and a high of ₹24.99

Launch of PATGPT

GlobalSpace Technologies launched PATGPT on 23 September 2025, introducing a game-changing AI-powered SaaS platform specifically designed for the pharmaceutical industry. The hybrid model is trained using a combination of the company’s proprietary pharma datasets and client-provided data hosted on secure cloud platforms. Initially, PATGPT will focus on optimizing sales, marketing, inventory, and distribution for pharmaceutical companies, with plans to expand its capabilities to support research and development, clinical trials, pharmacovigilance, and regulatory submissions in future phases.

Management Commentary

Looking back on the launch, Tania Mazumdar, Executive Director of GlobalSpace Technologies, called PATGPT a milestone for the company’s strategic entry into AI-based healthcare. She emphasized that the platform is a testament to GlobalSpace’s vision to be a market leader in digital and AI-driven solutions for the pharma sector.

REF:https://www.bseindia.com/xml-data/corpfiling/AttachLive/ad82a6c4-94dd-4b18-a397-641c00aab981.pdf

https://www.bseindia.com/xml-data/corpfiling/AttachLive/d74f779b-f874-4ea5-a4fd-b08ae19ce230.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations